Comments to: Relation between interleukin-13 and annexin-V levels and carotid intima-media thickness in nephrotic syndrome
DOI:
https://doi.org/10.33393/jcb.2024.3197Abstract
Not applicable
Downloads
References
Elsehmawy AA, Gouda RM, Diab FEAE, et al. Relation between interleukin-13 and annexin-V levels and carotid intima-media thickness in nephrotic syndrome. J Circ Biomark. 2024;13(1):7-13. https://doi.org/10.33393/jcb.2024.2689 PMID:38903854 DOI: https://doi.org/10.33393/jcb.2024.2689
Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34(4):290-296. doi: 10.1159/000343145. PMID: 23128470 DOI: https://doi.org/10.1159/000343145
Nixdorff U. [Intima-media thickness is a suitable surrogate marker for systemic atherosclerosis – contra]. Dtsch Med Wochenschr. 2009;134(40):2007. https://doi.org/10.1055/s-0029-1237548 PMID:19777417 DOI: https://doi.org/10.1055/s-0029-1237548
Bots ML, Evans GW, Riley WA, Grobbee DE. Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke. 2003;34(12):2985-2994. https://doi.org/10.1161/01.STR.0000102044.27905.B5 PMID:14615619 DOI: https://doi.org/10.1161/01.STR.0000102044.27905.B5
Polak JF, Johnson C, Harrington A, et al. Changes in carotid intima-media thickness during the cardiac cycle: the multi-ethnic study of atherosclerosis. J Am Heart Assoc. 2012;1(4):e001420. https://doi.org/10.1161/JAHA.112.001420 PMID:23130162 DOI: https://doi.org/10.1161/JAHA.112.001420
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Christian Saleh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors contributing to Journal of Circulating Biomarkers agree to publish their articles under the Creative Common Attribution Non Commercial 4.0 (CC-BY-NC 4.0) license, which allows third parties to re-use the work without permission as long as the work is properly referenced and the use is non-commercial.
Accepted 2024-08-26
Published 2024-09-25